By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Roche today said that the US Food and Drug Administration has approved its pre-analytical instrument, which provides "an integrated primary tube handling solution" for its Cobas automated molecular testing platform.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: factors influencing retrotransposon integration sites, and more.
A bioethicist argues for the responsible use of germline gene editing.
Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.
Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.